Literature DB >> 2094697

Improved fluorometric high-performance liquid chromatographic assay for (-)-carbovir in rat blood and urine.

R P Remmel1, S H Huang, D Hoff, C L Zimmerman.   

Abstract

Carbovir is a carbocyclic guanosine analogue with potent in vitro activity against the human immunodeficiency virus. All of the activity resides in the (-)-enantiomer. An ion-paired liquid chromatographic assay for (-)-carbovir was developed on a Spherisorb C8 column with fluorescence detection (275 nm excitation, 345 nm emission). Guanosine nucleosides are fluorescent at a pH less than 2.5, and fluorescence detection resulted in a four-fold improvement in the limit of quantitation (0.039 microgram/ml) compared to the previously developed assay with ultraviolet detection. Standard curves were processed with an internal standard at (-)-carbovir concentrations of 0.039-40 micrograms/ml in whole rat blood with a solid-phase extraction technique. Total variability was less than 16% at all concentrations and less than 10% at concentrations greater than 0.3 microgram/ml. Within-day variability was less than 7.5% at concentrations greater than 0.3 microgram/ml. Urine was analyzed directly after dilution and an diethyl ether wash to remove impurities. The total coefficients of variation were less than 10% from 0.5-20 micrograms/ml in urine. The concentrations of (-)-carbovir in rat blood were detectable for as long as 8 h after intravenous and oral doses of 20 and 60 mg/kg, respectively.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2094697     DOI: 10.1016/s0378-4347(00)82153-2

Source DB:  PubMed          Journal:  J Chromatogr


  3 in total

1.  The bioavailability and nonlinear clearance of (-)-carbovir in the rat.

Authors:  S H Huang; R P Remmel; C L Zimmerman
Journal:  Pharm Res       Date:  1991-06       Impact factor: 4.200

2.  Intestinal absorption of (-)-carbovir in the rat.

Authors:  I Soria; C L Zimmerman
Journal:  Pharm Res       Date:  1994-02       Impact factor: 4.200

3.  Comparative brain exposure to (-)-carbovir after (-)-carbovir or (-)-6-aminocarbovir intravenous infusion in rats.

Authors:  Y D Wen; R P Remmel; P T Pham; R Vince; C L Zimmerman
Journal:  Pharm Res       Date:  1995-06       Impact factor: 4.200

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.